Chromatin3D (642934)

  https://cordis.europa.eu/project/id/642934

  Horizon 2020 (2014-2020)

  Chromatin Dynamics in Development and Disease

  Marie Skłodowska-Curie Innovative Training Networks (ITN-ETN) (MSCA-ITN-2014-ETN)

  glaucoma  ·  DNA  ·  pathology  ·  RNA  ·  chromosomes

  2015-01-01 Start Date (YY-MM-DD)

  2018-12-31 End Date (YY-MM-DD)

  € 3,782,583 Total Cost


  Description

The cell nucleus is organized and compartmentalized into a highly ordered structure that contains DNA, RNA, chromosomal and histone proteins which make up a structure called chromatin. The dynamics associated with these various components are responsible for regulating physiological processes and the overall stability of the genome. The destabilization of such regulatory mechanisms that act on the chromatin structure are implicated in pathologies such as cancer. Higher order organization of chromatin results in chromosomes which occupy discrete territories within the cell nucleus. Most nuclear processes occur or at least being initiated onto the chromosomes which makes them the main organizing factors in the nucleus. Several proteins that are involved in the replication of DNA, gene transcription and the processing of RNA are found enriched in discrete focal structures. An emerging question is how these structures assemble and are maintained in the absence of membranes and moreover what are the kinetics of stable binding and/or rapid exchange of their components. The dynamic assembly and modification of chromatin during developmental processes as well as the deregulation of such chromatin dynamics during the onset of disease lacks mechanistic insights at present. To address these questions we have put forward a multidisciplinary approach which involves molecular, cellular and systems level approaches by assembling a group of scientists from academia and industry with cross disciplinary expertise and capabilities.


  Complicit Organisations

1 Israeli organisation participates in Chromatin3D.

Country Organisation (ID) VAT Number Role Activity Type Total Cost EC Contribution Net EC Contribution
Germany LIFEGLIMMER GMBH (953730482) DE282940451 partner PRC € 0 € 0 € 0
Germany LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (999978433) DE811205325 participant HES € 249,216 € 249,216 € 249,216
Italy ISTITUTO EUROPEO DI ONCOLOGIA SRL (999969703) IT08691440153 participant PRC € 93,188 € 93,188 € 93,188
Denmark EXIQON AS (999691119) DK18984431 partner PRC € 0 € 0 € 0
Israel WEIZMANN INSTITUTE OF SCIENCE (999979306) IL520016858 participant HES € 260,300 € 260,300 € 260,300
Belgium DIAGENODE (999755139) BE0480422786 participant PRC € 250,560 € 250,560 € 250,560
Greece IDRYMA TECHNOLOGIAS KAI EREVNAS (999995893) EL090101655 coordinator REC € 969,547 € 969,547 € 969,547
Germany SB SCIENCE MANAGEMENT UG (942580332) DE295533956 partner PRC € 0 € 0 € 0
Italy FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA (999596447) IT09198791007 participant REC € 164,872 € 164,872 € 164,872
Netherlands YELLOW RESEARCH (998263279) NL813630605B01 partner PRC € 0 € 0 € 0
Greece BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING (999458610) EL090052367 participant REC € 0 € 0 € 0
Sweden KAROLINSKA INSTITUTET (999978530) SE202100297301 participant HES € 527,318 € 527,318 € 527,318
United Kingdom AvantiCell Science Ltd (998500153) GB890505811 participant PRC € 273,287 € 273,287 € 273,287
Spain FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE (999600618) ESG58863317 participant REC € 247,872 € 247,872 € 247,872
Germany MOSAIQUES DIAGNOSTICS GMBH (999415445) DE213022344 participant PRC € 249,216 € 249,216 € 249,216
Hungary UD-GENOMED MEDICAL GENOMIC TECHNOLOGIES KUTATAS-FEJLESZTESI ES SZOLGALTATO KFT (993338007) HU14028793 participant PRC € 223,913 € 223,913 € 223,913
United Kingdom THE UNIVERSITY OF EDINBURGH (999974941) GB592950700 participant HES € 273,287 € 273,287 € 273,287